MarketPeel
Insider Trading Intelligence
VS

Vishwas Seshadri

ABEO
CHIEF EXECUTIVE OFFICER · ABEONA THERAPEUTICS INC. · CIK 0001865131
FILING MIX · LIFETIME38%/62%
BUYS
13
SELLS
21
TOTAL VALUE
$2.61M
COMPANIES
1
ACTIVE SINCE
Jun 2021
HOLDINGS NOW
1,374,079
AVG SELL PX
$4.58
TRADE KIND
SHOWING 34 / 34
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
12 backtested trades · 8 horizons · 18 pending
Forward-return performance of every backtestable P/S trade by Vishwas Seshadri, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d12+75.00%+5.92%-0.40%+6.32%+1.74%
14d12+58.33%+9.02%+0.99%+8.03%+3.54%
30d12+66.67%+10.37%+2.47%+7.91%-2.32%
60d12+75.00%+13.65%+3.43%+8.82%-4.38%
90d12+50.00%+9.63%+5.79%+3.84%+0.13%
180d12(2 pending)+80.00%+13.28%+8.90%+4.38%-7.13%
1y12(7 pending)+100.00%+25.74%+22.02%+3.72%+12.86%
2y12(9 pending)+100.00%+40.10%+47.13%-7.04%-21.07%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ABEO · 1,374,079 shares · as of Jun 9, 2026
0382,560765,1201,147,6801,530,24020222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 13 buys / 21 sellsCOVERAGE · 21 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ABEO
ABEONA THERAPEUTICS INC.
SALE
Chief Executive Officer
31,916$5.30$169.3K1,374,079Jun 9, 2026Jun 9, 2026View →
ABEO
ABEONA THERAPEUTICS INC.
SALE
Chief Executive Officer
24,428$5.43$132.6K1,405,995Jun 8, 2026Jun 9, 2026View →
ABEO
ABEONA THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
29,985$4.38$131.5K1,430,423Mar 31, 2026Mar 31, 2026View →
ABEO
ABEONA THERAPEUTICS INC.
SALE
Chief Executive Officer
69,832$5.33$372.3K1,460,408Jan 22, 2026Jan 22, 2026View →
ABEO
ABEONA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
365,4221,530,240Jan 20, 2026Jan 20, 2026View →
ABEO
ABEONA THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
25,000$5.31$132.7K1,164,818Dec 29, 2025Dec 29, 2025View →
ABEO
ABEONA THERAPEUTICS INC.
SALE
Chief Executive Officer
249$5.49$1.4K1,189,818Oct 16, 2025Oct 16, 2025View →
ABEO
ABEONA THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
25,000$5.24$130.9K1,190,067Sep 30, 2025Oct 1, 2025View →
ABEO
ABEONA THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
19,274$5.39$104.0K1,215,067Sep 29, 2025Oct 1, 2025View →
ABEO
ABEONA THERAPEUTICS INC.
SALE
Chief Executive Officer
69,420$5.86$406.5K1,234,341Jul 9, 2025Jul 10, 2025View →
ABEO
ABEONA THERAPEUTICS INC.
SALE
Chief Executive Officer
50,676$6.76$342.6K1,303,761Jun 6, 2025Jun 6, 2025View →
ABEO
ABEONA THERAPEUTICS INC.
SALE
Chief Executive Officer
885$6.24$5.5K1,354,437Jun 1, 2025Jun 3, 2025View →
ABEO
ABEONA THERAPEUTICS INC.
SALE10b5-1
10b5-1 plan
25,000$4.78$119.5K1,355,322Mar 31, 2025Mar 31, 2025View →
ABEO
ABEONA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
476,4351,380,322Jan 21, 2025Jan 23, 2025View →
ABEO
ABEONA THERAPEUTICS INC.
SALE
Chief Executive Officer
251$6.54$1.6K903,887Oct 16, 2024Oct 17, 2024View →
ABEO
ABEONA THERAPEUTICS INC.
SALE
Chief Executive Officer
18,798$5.89$110.7K904,138Sep 28, 2024Sep 30, 2024View →
ABEO
ABEONA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
424,000922,936Jul 8, 2024Jul 9, 2024View →
ABEO
ABEONA THERAPEUTICS INC.
SALE
Chief Executive Officer
38,621$4.52$174.6K498,936Jun 5, 2024Jun 7, 2024View →
ABEO
ABEONA THERAPEUTICS INC.
SALE
Chief Executive Officer
703$4.38$3.1K537,557Jun 3, 2024Jun 5, 2024View →
ABEO
ABEONA THERAPEUTICS INC.
PURCHASE
Chief Executive Officer
10,000$3.20$32.0K538,260Apr 25, 2024Apr 29, 2024View →
ABEO
ABEONA THERAPEUTICS INC.
PURCHASE
Chief Executive Officer
20,000$4.39$87.8K528,260Feb 6, 2024Feb 7, 2024View →
ABEO
ABEONA THERAPEUTICS INC.
SALE
Chief Executive Officer
181$4.14$749508,260Oct 16, 2023Oct 17, 2023View →
ABEO
ABEONA THERAPEUTICS INC.
SALE
Chief Executive Officer
13,290$3.93$52.2K508,441Sep 29, 2023Sep 29, 2023View →
ABEO
ABEONA THERAPEUTICS INC.
PURCHASE
Chief Executive Officer
20,000$4.07$81.4K521,731Sep 27, 2023Sep 29, 2023View →
ABEO
ABEONA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
336,826501,731Jun 5, 2023Jun 7, 2023View →
ABEO
ABEONA THERAPEUTICS INC.
SALE
Chief Executive Officer
827$3.06$2.5K164,905Jun 2, 2023Jun 6, 2023View →
ABEO
ABEONA THERAPEUTICS INC.
SALE
Chief Executive Officer
207$4.30$890165,732Oct 17, 2022Oct 18, 2022View →
ABEO
ABEONA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
155,200165,939Sep 28, 2022Sep 30, 2022View →
ABEO
ABEONA THERAPEUTICS INC.
SALE
Chief Executive Officer
81,525$0.16$13.0K268,475Jun 1, 2022Jun 17, 2022View →
ABEO
ABEONA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
300,000300,000Oct 15, 2021Oct 18, 2021View →
ABEO
ABEONA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
50,000350,000Oct 15, 2021Oct 18, 2021View →
ABEO
ABEONA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
100,000300,000Jun 1, 2021Jun 3, 2021View →
ABEO
ABEONA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
400,000400,000Jun 1, 2021Jun 3, 2021View →
ABEO
ABEONA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
200,000200,000Jun 1, 2021Jun 3, 2021View →
Other insiders · ABEO
Loading peer insiders…
About this filer
CIK 0001865131
ROLE
Chief Executive Officer
PRIMARY
ABEO
COMPANIES
1
ACTIVE SINCE
Jun 2021
MARKETPEEL · /INSIDER/0001865131DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback